COMPANY · NIPC 500189412

JANSSEN-CILAG FARMACEUTICA LDA

This page shows the public contracts the company has signed, which bodies gave them, and who it competed against.

Portal BASE records €1,810,618,101.78 across 7,180 contracts.

Follow (RSS) · What is RSS?

Identification

Company nameJANSSEN-CILAG FARMACEUTICA LDA
NIPC500189412
Registered officeLAGOAS PARK, EDIFICIO 9, 2740-262 PORTO SALVO
SourceTED (Jornal Oficial da UE), aviso 658696-2024
Record date29 October 2024

Contracted money

Sums of the contract prices on Portal BASE. A contract with several buyers or municipalities counts once in each row, so rows do not add up to the total.

Contracted value by yearBars with the value contracted in each year, from 2012 to 2026. The table below gives the same values.2012: €6,388,582.4820122013: €12,072,527.342014: €54,595,498.4820142015: €67,852,735.852016: €27,868,173.4620162017: €79,803,688.392018: €56,231,745.2320182019: €91,476,105.372020: €81,636,793.8720202021: €141,788,861.552022: €184,273,531.9920222023: €210,604,612.672024: €271,729,315.4520242025: €279,584,750.792026: €244,711,178.862026€279,584,750.79
Contracted value by year
YearContractsContract value
201255€6,388,582.48
2013121€12,072,527.34
2014216€54,595,498.48
2015240€67,852,735.85
2016267€27,868,173.46
2017397€79,803,688.39
2018390€56,231,745.23
2019487€91,476,105.37
2020635€81,636,793.87
2021795€141,788,861.55
2022741€184,273,531.99
2023673€210,604,612.67
2024712€271,729,315.45
2025807€279,584,750.79
2026644€244,711,178.86
Contracted value by place of performance
NameContractsContract value
Lisboa1127€524,813,343.70
Coimbra345€220,936,452.35
Porto694€198,452,939.34
Faro341€82,553,575.36
Setúbal552€70,530,433.80
Vila Nova de Gaia292€50,357,160.63
Braga123€48,994,581.84
Évora220€46,021,603.63
Viseu190€42,904,267.17
Almada374€38,204,343.10
Largest contracts
SubjectYearContract value
Medicamentos do foro oncológico - com base no CPA 2013/62015€31,589,591.37
060101162026 - 2026/0278 - Convite à apresentação de propostas ao abrigo do(s) acordo(s)-quadro 2023/0304 (Medicamentos do grupo 4: sangue), 2023/0436 (Medicamentos para o sistema nervoso central), 2023/0491 (Medica2026€16,500,690.96
418/2023 - Convite ao abrigo do(s) acordo(s)-quadro 2021/41 (Medicamentos antivíricos e antifúngicos), 2020/1 (Medicamentos do aparelho cardiovascular), 2022/40 (Medicamentos antirretrovíricos para o2023€15,056,726.16
2026/0278 - Convite à apresentação de propostas ao abrigo do(s) acordo(s)-quadro 2023/0304 (Medicamentos do grupo 4: sangue), 2023/0436 (Medicamentos para o sistema nervoso central), 2023/0491 (Medicamentos do foro oncológico e imunomodulad2026€14,228,823.67
P259-2021-127 - Convite ao abrigo do(s) acordo(s)-quadro 2019/40 (Medicamentos antirretrovíricos para o tratamento da infeção por VIH), 2019/55 (Medicamentos Diversos), 2020/1 (Medicamentos do Aparelh2022€14,150,289.24

Who they competed with

In 9,613 contracts with a list of competitors, the company took part and was awarded 2,161 (22%).

Companies with the most procedures in common
CompanyProcedures in common
generis478
mylan344
farmoz327
accord293
teva281
sandoz280
labesfal, sa242
pfizer236
hikma234
overpharma219
Novartis, S.A.205
Frsenius Kabi187
roche farmaceutica quimica180
Merck, Sharph & Dohme, Lda.174
logifarma164
Zentiva, Lda.157
Abbvie, Lda.143
pharmakern portugal135
sanofi132
bayer121
baxter121
b.braun116
Astrazeneca-Produtos Farmacêuticos, Lda114
unilfarma105
Bluepharma, S.A.105
Bristol-Myers103
Glaxosmithkline, Lda.94
profarin94
Pharmis Biofarmacêutica, Lda.94
Laboratórios normon, SA94

The annual IMPIC file lists competitors for about 42% of contracts. Only these enter the counts, and the award share is measured on them.

Links read in contract documents

Contract documents give addresses and the names of representatives and partners, and Portal BASE and GLEIF give competitors and groups. This is what the records show; the same address or name can have simple explanations.

Links read in contract documents38 companies and 60 links. The list below gives the same content as text.bayer (NIPC 500043256)bayerBristol-Myers (NIPC 500048193)Bristol-MyersNovartis, S.A. (NIPC 500063524)Novartis, S.A.sanofi (NIPC 500134960)sanofiGlaxosmithklin… (NIPC 500139962)Glaxosmithklin…pfizer (NIPC 500162166)pfizerJANSSEN-CILAG FARMACEUTIC… (NIPC 500189412)JANSSEN-CILAG FARMACEUTIC…Merck, Sharph … (NIPC 500191360)Merck, Sharph …roche farmaceu… (NIPC 500233810)roche farmaceu…unilfarma (NIPC 500293023)unilfarmalabesfal, sa (NIPC 501169580)labesfal, sa+27 in the list below

Dotted: competed in the same procedure. Dotted: same procedure.

48 more links

Investigations that mention it

No published investigation mentions this company by NIPC.